S&P Futures
5,912.25 +6.25 (+0.11%) Dow Futures
43,569.00 +51.00 (+0.12%) Nasdaq Futures
20,510.75 +27.25 (+0.13%) Russell 2000 Futures
2,296.30 +5.10 (+0.22%) Crude Oil
69.32 +0.10 (+0.14%) Gold
2,742.50 +12.50 (+0.46%)
Nanobiotix S.A. (NANO.PA)
| Previous Close | 4.4180 |
| Open | 4.4000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 4.4000 - 4.5220 |
| 52 Week Range | 3.8160 - 7.9300 |
| Volume | |
| Avg. Volume | 47,261 |
| Market Cap | 212.373M |
| Beta (5Y Monthly) | 1.29 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
11 Best Nanotechnology Stocks To Invest In
In this piece, we will take a look at the 11 best nanotechnology stocks to invest in. If you want to skip our introduction to the nanotechnology sector and how it covers a variety of applications ranging from healthcare to consumer technology, then you can skip ahead to read 5 Best Nanotechnology Stocks To Invest […]
- GuruFocus.com
Baillie Gifford Bolsters Stake in Nanobiotix SA
Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently increased its investment in Nanobiotix SA, a company at the forefront of nanotechnology in cancer treatment. This transaction was executed at a trade price of $5.81 per share, reflecting a 48.18% change in the firm's holdings and a 6.21% ownership in Nanobiotix SA. Despite the significant addition, the trade had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the position accounting for just 0.02% of its total investments.
